Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T05:01:18.969Z Has data issue: false hasContentIssue false

Large-diameter graft-stent (Advanta V12) implantation in various locations: early results

Published online by Cambridge University Press:  27 October 2010

Dietmar Schranz*
Affiliation:
Department of Paediatric Cardiology and Cardiac Surgery, Pediatric Heart Center, Justus-Liebig-University Giessen, Germany
Christian Jux
Affiliation:
Department of Paediatric Cardiology and Cardiac Surgery, Pediatric Heart Center, Justus-Liebig-University Giessen, Germany
Melanie Vogel
Affiliation:
Department of Paediatric Cardiology and Cardiac Surgery, Pediatric Heart Center, Justus-Liebig-University Giessen, Germany
Jürgen Bauer
Affiliation:
Department of Paediatric Cardiology and Cardiac Surgery, Pediatric Heart Center, Justus-Liebig-University Giessen, Germany
Hakan Akintürk
Affiliation:
Department of Paediatric Cardiology and Cardiac Surgery, Pediatric Heart Center, Justus-Liebig-University Giessen, Germany
Klaus Valeske
Affiliation:
Department of Paediatric Cardiology and Cardiac Surgery, Pediatric Heart Center, Justus-Liebig-University Giessen, Germany
*
Correspondence to: Professor Dr D. Schranz, Pediatric Heart Center, Justus-Liebig University, Feulgenstrasse 12, 35385 Giessen, Germany. Tel: 049 641 9943461 Fax: 049 641 9943469; E-mail: [email protected]

Abstract

Objectives

Transcatheter stent placement carries the risk of cardiovascular aneurysm or rupture. Covered stent implantation reduces these risks. The recently marketed Advanta V12 large-diameter-covered stent is pre-mounted and requires 9 (8)-11 Fr delivery systems. The aim was to report on the early results of the treatment of various cardiovascular obstructions by the implantation of a new polytetrafluoroethylene-covered stent (V12).

Methods

Graft stents on balloons with a diameter (12, 14, 16 millimetres) sufficient to anchor the stent in various obstructions (congenital aortic coarctation, n = 5; obstruction after ascending aorta repair, n = 2; pulmonary arteries, n = 5; inferior caval vein, n = 1; atretic superior caval vein, n = 1; pulmonary vein obstruction, n = 1; and right ventricular outflow tract, n = 1) were implanted using the smallest available delivery system. Secondary dilation with larger-diameter balloons was performed when the residual pressure was gradient, the stent-vessel wall relationship or stent re-coiling due to different reasons needed a re-intervention by pure ballooning or second stent placement.

Results

All 16 patients aged 5–46 years underwent V12 implantation. The variability of the treated lesions and the need for additional interventions were responsible for large ranges in fluoroscopy time between 7.3 to 48.2 minutes (median 17.3). Considering the additional procedures, the V12 stent achieved the desired result in all cases. There were no major complications. At short-term median follow-up of 2 months, all patients are alive and well with no evidence of stent failing.

Conclusion

These initial results show that the covered Advanta V12 large-diameter stent is safe and effective in the immediate treatment of various cardiovascular obstructions. Long-term follow-up is required.

Type
Original Articles
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. O’Laughlin, MP, Perry, SB, lock, JE, Mullins, CE. Use of endovascular stents in congenital heart disease. Circulation 1991; 83: 19231939.CrossRefGoogle ScholarPubMed
2. Fogelman, R, Nykanen, D, Smallhorn, JF, et al. Endovascular stents in the pulmonary circulation: clinical impact on management and medium-term follow-up. Circulation 1995; 92: 881885.CrossRefGoogle ScholarPubMed
3. Ebeid, MR, Prieto, LR, Latson, LA. Use of balloon-expandable stents for coarctation of the aorta: initial results and intermediate-term follow-up. J Am Coll Cardiol 1997; 30: 18471852.CrossRefGoogle ScholarPubMed
4. Ovaert, C, Calderone, CA, McCrindle, BW, et al. Endovascular stent implantation for the management of postoperative right ventricular outflow tract obstruction: clinical efficacy. J Thorac Cardiovasc Surg 1999; 118: 886893.CrossRefGoogle ScholarPubMed
5. Ing, F. Stents: what’s available to the pediatric interventional cardiologist’s. Catheter Cardiovasc Interv 2002; 57: 374386.CrossRefGoogle Scholar
6. Kreutzer, J, Rome, JJ. Open-cell design stents in congenital heart disease: a comparison of IntraStent vs Palmaz stents. Catheter Cardiovasc Interv 2002; 56: 400409.CrossRefGoogle ScholarPubMed
7. Hussein, H, Walsh, K. First in man use of the Advanta trademark V12 e PTFE-coated stent in aortic coarctation. Catheter Cardiovasc Interv 2009; 74: 101102.CrossRefGoogle Scholar
8. Bruckheimer, E, Birk, E, Santiago, R, Dagan, T, Esteves, C, Pedra, CAC. Coarctation of the aorta treated with the Advanta V12 large diameter stent: acute results. Catheter Cardiovasc Interv 2010; 75: 402406.CrossRefGoogle ScholarPubMed
9. Bokenkamp, R, Blom, N, deWolf, D, et al. Intraoperative stenting of pulmonary arteries. Eur J Cardiothorac Surg 2005; 27: 544547.CrossRefGoogle ScholarPubMed
10. Tomita, H, Yazaki, S, Kimura, K, et al. Potential goals for the dimensions of the pulmonary arteries and aorta with stenting after the Fontan operation. Catheter Cardiovasc Interv 2002; 56: 246253.CrossRefGoogle ScholarPubMed
11. Bacha, EA, Marshall, AC, McElhinney, DB, del Nido, PJ. Expanding the hybrid concept in congenital heart surgery. Semin Thorac Cardiovasc Surg pediatr Card Surg Annu 2007: 146150.CrossRefGoogle ScholarPubMed
12. Ing, FF, Grifka, RG, Nihill, MR, Mullins, CE. Repeat dilatation of intravascular stents in congenital heart defects. Circulation 1995; 92: 893897.CrossRefGoogle ScholarPubMed
13. Carano, N, Agnetti, A, Tchana, B, Squarcia, A, Saquarcia, U. Descending thoracic aorta to left pulmonary fistula after stent implantation for acquired left pulmonary artery stenosis. J Interv Cardiol 2002; 15: 11413.CrossRefGoogle ScholarPubMed
14. Ewert, P, Schubert, S, Peters, B, Abdul-Khaliq, H, Nagdyman, N, Lange, PE. The CP stent – short, long, covered – for the treatment of aortic coarctation, stenosis of pulmonary arteries and caval veins, and Fontan anastomosis in children and adults: an evaluation of 60 stents in 53 patients. Heart 2005; 91: 948953.CrossRefGoogle Scholar